Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Sell
26
AKYA Quote, Financials, Valuation and Earnings
Last price:
$1.23
Seasonality move
:
-6.87%
Day range:
$1.26 - $1.32
52-week range:
$0.93 - $3.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.79x
P/B ratio:
6.20x
Volume:
236.2K
Avg. volume:
771.6K
1-year change:
-35.37%
Market cap:
$63.3M
Revenue:
$81.7M
EPS (TTM):
-$0.97
Earnings Data
Next earnings date for AKYA
Aug 05
2025
Most recent earnings per share
-$0.32
Missed by $0.09
(May 12/2025)
Consensus Estimate
-$0.23
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKYA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/05/2025 | Q2 | $18.1M | -- | -- | -$0.23 | -- |
| 05/12/2025 | Q1 | $19.3M | $16.6M | -$0.32 | -$0.23 | -$0.09 |
| 03/17/2025 | Q4 | $21.3M | $21.3M | -$0.17 | -$0.16 | -$0.01 |
| 11/14/2024 | Q3 | $25.4M | $18.8M | -$0.21 | -$0.20 | -$0.01 |
| 08/05/2024 | Q2 | $23.6M | $23.2M | -$0.27 | -$0.27 | $0.00 |
| 05/13/2024 | Q1 | $24.3M | $18.4M | -$0.48 | -$0.29 | -$0.19 |
| 03/04/2024 | Q4 | $26.1M | $26.5M | -$0.22 | -$0.27 | $0.05 |
| 11/08/2023 | Q3 | -- | -- | -$0.26 | -$0.36 | $0.10 |
| 08/07/2023 | Q2 | -- | -- | -$0.51 | -$0.44 | -$0.07 |
| 05/08/2023 | Q1 | -- | -- | -$0.49 | -$0.48 | -$0.01 |
| 03/06/2023 | Q4 | -- | -- | -$0.50 | -$0.43 | -$0.07 |
| 11/07/2022 | Q3 | -- | -- | -$0.47 | -$0.44 | -$0.03 |
| 08/08/2022 | Q2 | -- | -- | -$0.47 | -$0.36 | -$0.11 |
| 05/05/2022 | Q1 | -- | -- | -$0.44 | -$0.38 | -$0.06 |
| 03/14/2022 | Q4 | -- | -- | -$0.47 | -$0.31 | -$0.16 |
| 11/08/2021 | Q3 | -- | -- | -$0.31 | -$0.27 | -$0.04 |
| 08/10/2021 | Q2 | -- | -- | -$0.20 | -$0.23 | $0.03 |
| 05/18/2021 | Q1 | -- | -- | -$0.23 | -$0.17 | -$0.06 |
| 12/31/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.07 | -- | -- |
Akoya Biosciences Earnings Questions
-
How Much did Akoya Biosciences Generate in Revenue Last Quarter?
Akoya Biosciences reported $16.6M worth of top line sales in its most recent quarter.
-
Did Akoya Biosciences Beat Earnings Last Quarter?
Akoya Biosciences announced earnings per share of -$0.32 which represents a miss of analyst forecast a -$0.23 per share.
-
Is Akoya Biosciences Profitable?
Akoya Biosciences reported $9.9M that represents $0.20 per share over the last quarter.
-
What is the Analyst Consensus for Akoya Biosciences EPS Next Year?
Akoya Biosciences's earnings are forecast to decrease from -$1.12 per share to -$1.07 per share next year representing a decrease of -22.32%.
-
When is Akoya Biosciences's Earnings Date?
Akoya Biosciences's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
